Jefferies Financial Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $884K | Sell |
22,381
-460
| -2% | -$18.2K | 0.01% | 552 |
|
|
2025
Q1 | $689K | Buy |
22,841
+460
| +2% | +$13.9K | 0.01% | 760 |
|
|
2024
Q4 | $782K | Sell |
22,381
-30,400
| -58% | -$1.06M | ﹤0.01% | 731 |
|
|
2024
Q3 | $2.11M | Sell |
52,781
-9,419
| -15% | -$377K | 0.02% | 414 |
|
|
2024
Q2 | $2.96M | Sell |
62,200
-130,880
| -68% | -$6.24M | 0.03% | 312 |
|
|
2024
Q1 | $8.37M | Sell |
193,080
-9,220
| -5% | -$400K | 0.08% | 116 |
|
|
2023
Q4 | $10.2M | Buy |
202,300
+42,090
| +26% | +$2.13M | 0.07% | 113 |
|
|
2023
Q3 | $7.27M | Buy |
160,210
+67,210
| +72% | +$3.05M | 0.07% | 113 |
|
|
2023
Q2 | $3.82M | Buy |
+93,000
| New | +$3.82M | 0.03% | 244 |
|
|
2023
Q1 | – | Sell |
-197,009
| Closed | -$7.44M | – | 1284 |
|
|
2022
Q4 | $7.44M | Buy |
+197,009
| New | +$7.44M | 0.05% | 127 |
|